Results 151 to 160 of about 26,826 (219)

Myotonic dystrophy

, 2019
Yuranga Weerakkody, Arlene Campos, Daniel Bell   +2 more
openaire   +1 more source

Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1. [PDF]

Mol Ther
Tomassy GS, Fan W, Cao S, Luo Z, Magli A, Zhang T, Boyle K, Jackson R, Richards B, Liu D, Rapaport F, Khader S, Pfister EL, O'Riordan C, Frederick A, Sullivan J, Cao J, Nageswara Rao K, Assaf BT, Goulet M, Mueller C.   +20 more
europepmc   +1 more source

Cortical thinning and white matter alterations in myotonic dystrophy type 2 over a 10-year period. [PDF]

J Neurol
Krieger B, Schneider-Gold C, Genç E, Güntürkün O, Prehn C, Bellenberg B, Lukas C.   +6 more
europepmc   +1 more source

Risk of Cardiac Disease in a Population-Based Cohort of Myotonic Dystrophy Type 1 and Type 2 in the United States. [PDF]

Neurol Genet
Johnson NE, Bhandaru V, Andrews JG, Jaff T, Venkatesh YS, Raucci FJ, Soim A, Ciafaloni E, Rice MM, as the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).   +11 more
europepmc   +1 more source

Fifteen Years of Myotonic Dystrophy Type 1 in Mexico: Clinical, Molecular, and Socioeconomic Insights from a National Reference Cohort. [PDF]

Genes (Basel)
Cerecedo-Zapata CM, Guerra-Grajeda A, Márquez-Quiróz LC, Arciga-Portela P, Escobar-Cedillo RE, Jiménez-Gutiérrez GE, Pérez-Méndez ÓA, Velasco-Flores JS, Barredo-Prieto BA, Leyva-García N, Cisneros B, Murillo-Melo NM, Magaña JJ.   +12 more
europepmc   +1 more source

Pre- and postsynaptic upregulation of FasII synergistically underlies neuropathological and behavioral phenotypes in a Drosophila model of myotonic dystrophy. [PDF]

Nat Commun
Koon AC, Yeung KYW, Wu Y, Leong LI, Cheung JTP, Chen ZS, Peng SI, Armstrong NS, Frank CA, Magneron P, Gomes-Pereira M, Fung JMS, Bargiela A, Moreno N, Poyatos-Garcia J, Vilchez J, Huguet-Lachon A, Brewer CK, Zinter M, Beck ES, Artero R, Gourdon G, Budnik V, Thomson T, McCabe BD, Chan HYE.   +25 more
europepmc   +1 more source

Co-Opting MBNL-Dependent Alternative Splicing Cassette Exons to Control Gene Therapy in Myotonic Dystrophy. [PDF]

Ann Neurol
Carrell ST, Carrell EM, Giovenco R, Davidson BL.   +3 more
europepmc   +1 more source

circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1. [PDF]

Mol Ther Nucleic Acids
Baci D, Tastsoglou S, Provenzano C, Perfetti A, Izzo M, Lisanti M, Frolova S, Voellenkle C, Tascini AS, Cardani R, Cardinali B, Meola G, Falcone G, Martelli F.   +13 more
europepmc   +1 more source

Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. [PDF]

Int J Mol Sci
Jennings K, Tian C, Brown RL, Horn PS, Schoser B, Kushlaf H, Timchenko NA, Timchenko L.   +7 more
europepmc   +1 more source